IDH1 and cancer: Among all tested cancer genes, whether deleted, amplified or mutated, IDH1 was the only one with negative log2 odds ratio, i.e. it was mutually exclusive of FHIT deletion, meaning that cancers with significantly mutated IDH1 genes do not show FHIT allele loss.